530 related articles for article (PubMed ID: 15727649)
1. Psychosocial aspects of patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A.
Weber A; Heger S; Sinkgraven R; Heckmann M; Elsner P; Rzany B
Br J Dermatol; 2005 Feb; 152(2):342-5. PubMed ID: 15727649
[TBL] [Abstract][Full Text] [Related]
2. No compensatory sweating after botulinum toxin treatment of palmar hyperhidrosis.
Krogstad AL; Skymne A; Pegenius G; Elam M; Wallin BG
Br J Dermatol; 2005 Feb; 152(2):329-33. PubMed ID: 15727647
[TBL] [Abstract][Full Text] [Related]
3. The successful use of botulinum toxin for the treatment of nasal hyperhidrosis.
Geddoa E; Balakumar AK; Paes TR
Int J Dermatol; 2008 Oct; 47(10):1079-80. PubMed ID: 18986362
[TBL] [Abstract][Full Text] [Related]
4. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life.
Solish N; Benohanian A; Kowalski JW;
Dermatol Surg; 2005 Apr; 31(4):405-13. PubMed ID: 15871315
[TBL] [Abstract][Full Text] [Related]
5. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
Vadoud-Seyedi J; Simonart T
Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin improves the quality of life and reduces the intensification of depressive symptoms in patients with blepharospasm.
Ochudlo S; Bryniarski P; Opala G
Parkinsonism Relat Disord; 2007 Dec; 13(8):505-8. PubMed ID: 17543569
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
Naumann M; Lowe NJ; Kumar CR; Hamm H;
Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin A for quality of life improvement in post-parotidectomy gustatory sweating (Frey's syndrome).
Hartl DM; Julieron M; LeRidant AM; Janot F; Marandas P; Travagli JP
J Laryngol Otol; 2008 Oct; 122(10):1100-4. PubMed ID: 18289458
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis.
Absar MS; Onwudike M
Dermatol Surg; 2008 Jun; 34(6):751-5. PubMed ID: 18318723
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life after thoracoscopic sympathectomy for palmar hyperhidrosis.
Kumagai K; Kawase H; Kawanishi M
Ann Thorac Surg; 2005 Aug; 80(2):461-6. PubMed ID: 16039186
[TBL] [Abstract][Full Text] [Related]
13. Depression and social phobia secondary to alcohol dependence.
Olgiati P; Liappas I; Malitas P; Piperi C; Politis A; Tzavellas EO; Zisaki A; Ferrari B; De Ronchi D; Kalofoutis A; Serretti A
Neuropsychobiology; 2007; 56(2-3):111-8. PubMed ID: 18182831
[TBL] [Abstract][Full Text] [Related]
14. Bilateral thoracoscopic T2 to T3 sympathectomy versus botulinum injection in palmar hyperhidrosis.
Ambrogi V; Campione E; Mineo D; Paternò EJ; Pompeo E; Mineo TC
Ann Thorac Surg; 2009 Jul; 88(1):238-45. PubMed ID: 19559233
[TBL] [Abstract][Full Text] [Related]
15. [Focal hyperhidrosis: disease characteristics and treatments].
Campanelli A; Salomon D
Rev Med Suisse; 2009 Apr; 5(200):870-5. PubMed ID: 19438086
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
Heckmann M; Ceballos-Baumann AO; Plewig G;
N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
[TBL] [Abstract][Full Text] [Related]
17. Effect and persistency of botulinum toxin iontophoresis in the treatment of palmar hyperhidrosis.
Davarian S; Kalantari KK; Rezasoltani A; Rahimi A
Australas J Dermatol; 2008 May; 49(2):75-9. PubMed ID: 18412805
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A therapy for palmar and digital hyperhidrosis.
Solomon BA; Hayman R
J Am Acad Dermatol; 2000 Jun; 42(6):1026-9. PubMed ID: 10827408
[TBL] [Abstract][Full Text] [Related]
19. Treatment of plantar hyperhidrosis with botulinum toxin type A.
Vadoud-Seyedi J
Int J Dermatol; 2004 Dec; 43(12):969-71. PubMed ID: 15569036
[TBL] [Abstract][Full Text] [Related]
20. Axillary injection of botulinum A toxin in a patient with muscle cramps associated with severe axillary hyperhidrosis.
Filosto M; Bertolasi L; Fincati E; Priori A; Tomelleri G; Chieregato G; Rizzuto N
Acta Neurol Belg; 2001 Jun; 101(2):121-3. PubMed ID: 11486559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
